To further explore function of GPR84 in chronic intestinal inflammation and carcinogenesis, a model of inflammation-associated colon cancer was induced with intraperitoneal injection of AOM, followed by cyclic DSS (1.5%) treatment (Supplementary Fig. S2a), as described previously [31, 34]. This evidence concerns the gene GPR84 and colonic neoplasm.